The first peer-reviewed study in North America examining dosing intervals for COVID-19 mRNA vaccines shows a delayed second dose leads to a stronger immune response. CHÉOS Scientist and principal investigator… Read More
50/50 joint venture with investor syndicate led by Frazier Healthcare Partners and Pivotal bioVenture Partners China Expands global reach and execution for Chinook’s atrasentan and BION-1301 programs in IgA nephropathy (IgAN) SEATTLE… Read More
Are you an early-stage BC tech start-up that could use 12 months of FREE office space, professional memberships, business education allowance, one-on-one mentorship, and networking opportunities? The GENERATOR 12.0 Competition… Read More
VANCOUVER, BC – NervGen Pharma Corp.(TSX-V: NGEN; OTCQX: NGENF)(“NervGen” the “Company”), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, is pleased to… Read More
Dr. Peter Stirling (Stirling Lab) and co-principal investigators Dr. David Huntsman (Huntsman Lab), Philip Hieter (UBC) and Jean-Yve Masson (Laval University) were awarded a 2021 OvCAN/Ovarian Cancer Canada-Cancer Research Society Grant for… Read More
